Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENERGI-F703 GEL in diabetic foot ulcers
NCT05930210Phase 3Recruiting
- Sponsor
- Energenesis Biomedical Co., Ltd.
- Start
- May 2023
- Primary completion
- Dec 2025
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ENERGI-F703EB Cream in diabetic foot ulcer (DFU), sponsored by Energenesis Biomedical Co., Ltd.. Started May 2023; status: recruiting.
02
Drugs
ENERGI-F703EB Cream
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT05930210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05930210.